Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Some drugs may help treat both COVID-19 and radiation injury.

Global collaboration in dermatology improved data sharing and patient care during COVID-19.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

Gender and social factors, not just biology, affect COVID-19 death rates.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Antiandrogens don't help with COVID-19 and aren't recommended.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

People in high-income countries are more likely to accept COVID-19 booster doses than those in middle or low-income countries.

Long-COVID causes more health issues after COVID-19, varying by age, sex, and infection wave.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Natural products might help treat COVID-19, but current drugs like hydroxychloroquine haven't worked.

Age, health conditions, race, and gender affect COVID-19 risk.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

iPSCs are promising for studying and treating COVID-19.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

Higher oxidative stress markers are linked to hair loss in post-COVID-19 patients.